Drug
Ts-134
Ts-134 is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
4
100%
Phase Distribution
4
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
4(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 14 (100.0%)
Trials by Status
completed375%
recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
recruitingphase_1
Glutamatergic Mechanisms: Aim2
NCT05401227
completedphase_1
Safety, Tolerability and Pharmacokinetics of Single Doses of TS-134 in Healthy Volunteers
NCT03746067
completedphase_1
Safety, Tolerability and Pharmacokinetics of 14-day Multiple Dose Titrations of TS-134 in Healthy Volunteers
NCT03742791
completedphase_1
Effects of TS-134 on Ketamine-induced BOLD Signals in Healthy Subjects
NCT03141658
Clinical Trials (4)
Showing 4 of 4 trials
NCT05401227Phase 1
Glutamatergic Mechanisms: Aim2
NCT03746067Phase 1
Safety, Tolerability and Pharmacokinetics of Single Doses of TS-134 in Healthy Volunteers
NCT03742791Phase 1
Safety, Tolerability and Pharmacokinetics of 14-day Multiple Dose Titrations of TS-134 in Healthy Volunteers
NCT03141658Phase 1
Effects of TS-134 on Ketamine-induced BOLD Signals in Healthy Subjects
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4